Of course, there are still many shortcomings in our study, whether KIRREL has an effect on the malignant phenotype of GC in vivo we have not yet studied, as well as the design of small‐molecule inhibitors targeting KIRREL, which are the direction and content of the next step of our research. This evidence concerns the gene KIRREL1 and gastric cancer.